Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
9.99
-0.48 (-4.58%)
May 13, 2025, 4:00 PM - Market closed

Rapport Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
May '25 Dec '24 Dec '23 Dec '22
Market Capitalization
365649--
Enterprise Value
87330--
Last Close Price
9.9917.74--
Debt / Equity Ratio
0.030.010.050.54
Quick Ratio
30.4234.8216.7518.74
Current Ratio
31.0135.3417.1418.80
Return on Equity (ROE)
-33.14%-35.09%-43.36%-
Return on Assets (ROA)
-22.88%-22.07%-24.18%-
Return on Capital (ROIC)
-23.71%-22.86%-25.52%-
Buyback Yield / Dilution
-1632.08%-1277.25%-93.74%-
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q